To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Carlyle to take stake in Salubris
The Carlyle Group has agreed to acquire a 5 percent stake in Salubris, a China-based biopharmaceutical company.
